Joshua Jergensen

PACS President & COO Joshua Jergensen sells 40,000 shares ($1.8M) via 10b5-1 plan; holds 2,576,320 post-transaction

Joshua Jergensen executed three separate sales totaling 40,000 shares for $1,800,717.71 at a blended average price of $45.02 on 2026-07-15. This sale was part of a pre-arranged 10b5-1 trading plan adopted on 2026-03-12, making it scheduled rather than discretionary. The current stock price of $45.63 is -1.6% from the 52-week high of $46.38, and the 30-day and 90-day changes show +27.1% and +29.6% respectively. His prior sell at PACS on 2026-03-13 showed 30-day return of -1.6% and 90-day return of +1.4%, providing limited pattern evidence specific to this ticker.

PACS President & COO Jergensen sells 36,335 shares at $34.28; retains 2,667,347 shares post-transaction

Jergensen, in his role as President & COO, executed a discretionary sale of 36,335 shares at $34.28 on 2026-03-13, representing a -1.3% reduction in his pre-transaction holdings of 2,703,682 shares. The sale occurred at a price -15.3% below the 52-week high of $42.13, during a 30-day period of -5.6% price weakness. Post-transaction, he retains 2,667,347 shares (2.67M shares), maintaining substantial common ownership. The company's fundamentals remain robust: $1.3B quarterly revenue with +29.3% annual growth, $52.4M net income, and an 18.40 P/E ratio at a $5.6B market cap. The modest sale size and retention of substantial holdings do not indicate a material shift in insider positioning, though the timing relative to recent price weakness warrants noting as part of the transaction record.